Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Fortis Healthcare...

    Fortis Healthcare International to sell entire stake in MSCL

    GarimaWritten by Garima Published On 2019-05-19T10:00:03+05:30  |  Updated On 19 May 2019 10:00 AM IST
    Fortis Healthcare International to sell entire stake in MSCL

    Mauritius-based Fortis Healthcare International holds 28.89 per cent stake in Medical and Surgical Centre Ltd (MSCL).


    New Delhi: Fortis Healthcare Friday said its subsidiary Fortis Healthcare International Ltd(FHIL) will sell its entire stake in Medical and Surgical Centre Ltd (MSCL).


    Mauritius-based FHIL holds 28.89 per cent stake in MSCL.


    Also Read: Fortis tightens financial noose around Singh brothers; likely to move Delhi HC










    "Fortis Healthcare International Ltd (FHIL), a wholly owned subsidiary of Fortis Healthcare Ltd, which is incorporated in Mauritius, has entered into a share purchase agreement with CIEL Ltd, CIEL Healthcare Ltd and MSCL, for, sale of the entire shareholding held by FHIL in MSCL, representing 28.89 per cent (164,670,801 shares) holding of the total issued and paid up equity share capital of MSCL," it said in a regulatory filing.








    It added that the proposed transaction is subject to the approval of Fortis Healthcare Ltd's shareholders as well as regulatory approvals, if required.


    "Upon consummation of the proposed transaction, the entire stake of FHIL in MSCL will be divested," it added.


    Also Read: SEBI asks Fortis to recover Rs 403 crore from Singh Brothers; FHL informs HC

    ABN AMROABN AMRO GroupBankingBNP ParibasCIEL Healthcare LtdCIEL LtdFHILFHLFinancefinancial servicesFortisFortis HealthcareFortis Healthcare International LtdFortis Healthcare Ltdfortis stakeMauritiusMedical and Surgical Centre LtdMSCLSurgical Centre Ltd
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok